I agree.
People want a partnership but don't want any dilution. The reality is they go hand in hand nearly every time.
We are also unlikely to get a partnership if the trial designs are not suitable for pharma to pick up and run with.
I asked a lot of questions about funding so I understand the angst there. However, I was more interested in seeing the funding possibilities - not wanting to change the strategy to suit the current budget.
Some holders need to remember that you can't eat your cake and have it too.
Ann: Race Board and Management Team Changes, page-350
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.66 |
Change
-0.030(1.78%) |
Mkt cap ! $282.0M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.69 | $1.65 | $126.2K | 76.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 120 | $1.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.67 | 500 | 1 |
View Market Depth
| Last trade - 13.57pm 03/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |